Data / Drug companies / Village Pharma LLC
Village Pharma LLC: 16 products in the FDA NDC directory, labeler code 71574
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Village Pharma LLC (labeler code 71574) lists 16 products in the FDA National Drug Code Directory, covering 7 finished drugs by generic name. By type: 8 over the counter drugs, 7 bulk ingredients. Its main marketing category is over the counter monograph drugs. The newest product started marketing on October 21, 2022.
The request: Watch Village Pharma LLC (FDA labeler code 71574): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 71574
- Products in commercial distribution
- 16
- Packages
- 16
- Finished drugs by generic name
- 7
- Prescription products
- 1
- Over the counter products
- 8
- Flagged as original packager
- 9 of 9 products that carry the flag
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- May 11, 2016
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 8 | 50% |
| Bulk ingredients | 5 | 31.2% |
| Bulk ingredients for compounding | 2 | 12.5% |
| Generic drugs (ANDA) | 1 | 6.2% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 8 | 50% |
| Bulk ingredients | 7 | 43.8% |
| Prescription drugs | 1 | 6.2% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Methyl salicylate, menthol, capsaicin | 2 | 6 |
| Lidocaine hydrochloride, menthol | 2 | 14 |
| Menthol, capsaicin | 1 | 8 |
| Lidocaine, menthol | 1 | 34 |
| Sennosides 8.6mg and docusate sodium 50mg | 1 | 5 |
| Dimethicone | 1 | 69 |
| Triamcinolone acetonide, dimethicone | 1 | 1 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 5 | 31.2% |
| Kit | 3 | 18.8% |
| Patch | 2 | 12.5% |
| Cream | 2 | 12.5% |
| Gel | 2 | 12.5% |
| Tablet | 1 | 6.2% |
| Lotion | 1 | 6.2% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Amide Local Anesthetic | 3 |
| Antiarrhythmic | 3 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Gabapentin, ketoprofen and lidocaine | 71574-120 | Kit | Bulk ingredients for compounding | October 21, 2022 |
| Lidozen Patch | 71574-905 | Patch | Over the counter monograph drugs | September 1, 2022 |
| Menthozen Cream | 71574-605 | Cream | Over the counter monograph drugs | September 1, 2022 |
| Lidozen Gel | 71574-305 | Gel | Over the counter monograph drugs | September 1, 2022 |
| Flurbiprofen and cyclobenzaprine | 71574-110 | Kit | Bulk ingredients for compounding | July 11, 2022 |
| Lidocaine | 71574-124 | Powder | Bulk ingredients | May 25, 2022 |
| Menthozen Hydrogel | 71574-601 | Patch | Over the counter monograph drugs | July 1, 2019 |
| Docuzen | 71574-700 | Tablet | Over the counter monograph drugs | November 27, 2018 |
| Menthozen | 71574-600 | Cream | Over the counter monograph drugs | October 1, 2018 |
| Scarzen | 71574-500 | Lotion | Over the counter monograph drugs | August 1, 2018 |
| Ketoprofen | 71574-122 | Powder | Bulk ingredients | September 1, 2017 |
| Gabapentin | 71574-121 | Powder | Bulk ingredients | September 1, 2017 |
| Cyclobenzaprine hydrochloride | 71574-112 | Powder | Bulk ingredients | September 1, 2017 |
| Flurbiprofen | 71574-111 | Powder | Bulk ingredients | September 1, 2017 |
| Lidozen | 71574-300 | Gel | Over the counter monograph drugs | July 22, 2017 |
| Scarzen | 71574-501 | Kit | Generic drugs (ANDA) | May 11, 2016 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.